GB0316680D0 - Anti-activated RAS antibodies - Google Patents

Anti-activated RAS antibodies

Info

Publication number
GB0316680D0
GB0316680D0 GB0316680A GB0316680A GB0316680D0 GB 0316680 D0 GB0316680 D0 GB 0316680D0 GB 0316680 A GB0316680 A GB 0316680A GB 0316680 A GB0316680 A GB 0316680A GB 0316680 D0 GB0316680 D0 GB 0316680D0
Authority
GB
United Kingdom
Prior art keywords
activated ras
ras antibodies
antibodies
activated
ras
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0316680A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Research Council filed Critical Medical Research Council
Priority to GB0316680A priority Critical patent/GB0316680D0/en
Publication of GB0316680D0 publication Critical patent/GB0316680D0/en
Priority to EP03773865A priority patent/EP1565495A2/en
Priority to JP2004570301A priority patent/JP2006521088A/en
Priority to PCT/GB2003/004953 priority patent/WO2004046188A2/en
Priority to CA002506128A priority patent/CA2506128A1/en
Priority to AU2003282247A priority patent/AU2003282247A1/en
Priority to US11/127,903 priority patent/US20050288492A1/en
Ceased legal-status Critical Current

Links

GB0316680A 2002-11-15 2003-07-16 Anti-activated RAS antibodies Ceased GB0316680D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GB0316680A GB0316680D0 (en) 2003-07-16 2003-07-16 Anti-activated RAS antibodies
EP03773865A EP1565495A2 (en) 2002-11-15 2003-11-14 Anti-activated ras antibodies
JP2004570301A JP2006521088A (en) 2002-11-15 2003-11-14 Anti-activated RAS antibody
PCT/GB2003/004953 WO2004046188A2 (en) 2002-11-15 2003-11-14 Anti-activated ras antibodies
CA002506128A CA2506128A1 (en) 2002-11-15 2003-11-14 Anti-activated ras antibodies
AU2003282247A AU2003282247A1 (en) 2002-11-15 2003-11-14 Anti-activated ras antibodies
US11/127,903 US20050288492A1 (en) 2002-11-15 2005-05-12 Anti-activated RAS antibodies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0316680A GB0316680D0 (en) 2003-07-16 2003-07-16 Anti-activated RAS antibodies

Publications (1)

Publication Number Publication Date
GB0316680D0 true GB0316680D0 (en) 2003-08-20

Family

ID=27763948

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0316680A Ceased GB0316680D0 (en) 2002-11-15 2003-07-16 Anti-activated RAS antibodies

Country Status (1)

Country Link
GB (1) GB0316680D0 (en)

Similar Documents

Publication Publication Date Title
EP1616881A4 (en) Anti-mpl antibodies
IL243914A0 (en) Anti-vegf antibodies
IL246594A0 (en) Treatment with anti-vegf antibodies
IL175608A0 (en) Antibodies
PT1599504E (en) Modified antibody
IL173557A0 (en) Variable antibodies
EP1494693A4 (en) Cripto-specific antibodies
EP1648512A4 (en) Anti-cd19 antibodies
PL375405A1 (en) Antibodies
GB0305702D0 (en) Bispecific antibodies
AP2006003510A0 (en) Modified human IGF-1R antibodies.
EP1682512A4 (en) Immunohistochemical methods
EP1677112A4 (en) Immunoassay
IL172511A0 (en) Specific human antibodies
EP1608729A4 (en) Rnai arrays and methods for using the same
GB0305448D0 (en) Immunoassay
GB0306618D0 (en) Antibody
GB0302699D0 (en) Immunoglobulin
GB0316680D0 (en) Anti-activated RAS antibodies
GB0226878D0 (en) Antibodies
GB0226728D0 (en) Anti-activated RAS antibodies
HK1209139A1 (en) Modified antibody
GB0329711D0 (en) Antibodies
GB0319118D0 (en) Variable antibodies
GB0319345D0 (en) Variable antibodies

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)